LY6G6D Recombinant Monoclonal Antibody

Code CSB-RA013246MA1HU
Size US$210
Order now
Image
  • The Binding Activity of LY6G6D with anti-LY6G6D antibody
    Activity: Measured by its binding ability in a functional ELISA. Immobilized Macaca fascicularis LY6G6D(CSB-YP4607MOV) at 2 μg/mL can bind Anti-LY6G6D recombinant antibody, the EC50 is 3.963-7.154 ng/mL.
  • The Binding Activity of LY6G6D with anti-LY6G6D antibody
    Activity: Measured by its binding ability in a functional ELISA. Immobilized Human LY6G6D(CSB-YP013246HU) at 2 μg/mL can bind Anti-LY6G6D recombinant antibody, the EC50 is 2.816-3.741 ng/mL.
  • Untransfected HEK293T cells surface (green line) and transfected Human LY6G6D HEK293T stable cells surface(red line) were stained with anti-LY6G6D antibody (CSB-RA013246MA1HU) (2µg/1*106cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
LY6G6D
Alternative Names
Lymphocyte antigen 6 complex locus protein G6d; Protein Ly6-D; Megakaryocyte-enhanced gene transcript 1 protein; LY6G6D; C6orf23; G6D; MEGT1; NG25
Species Reactivity
Human, Macaca fascicularis
Immunogen
Recombinant Human LY6G6D protein
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Monoclonal
Isotype
hIgG1
Clone No.
8I8
Purification Method
Affinity-chromatography
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, FC
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Description

The creation of the LY6G6D recombinant monoclonal antibody involves the following steps: 1. LY6G6D antibody generation. Use the recombinant human LY6G6D protein as the immunogen to induce an immune reaction and harvest B cells. 2. Gene cloning. Extract total RNA from the harvested B cells. Convert the RNA into cDNA using reverse transcription. Amplify the LY6G6D antibody genes using PCR with primers specific to the antibody constant regions. Clone the antibody genes into an expression vector. 3. Recombinant antibody expression and purification. Transfect the expression vector containing the LY6G6D antibody genes into host cells for antibody expression. Collect the cell culture supernatant and purify the LY6G6D recombinant monoclonal antibody using affinity chromatography. 4. Antibody characterization and validation. This purified antibody has been tested to recognize and bind to the human and macaca fascicularis LY6G6D protein in ELISA and FC.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Gene References into Functions
  1. Frequencies of the DRB1, DQA1, DQB1 and TNFA alleles in immigrant population of West Siberia PMID: 19807019
Subcellular Location
Cell membrane; Lipid-anchor, GPI-anchor. Cell projection, filopodium.
Tissue Specificity
Expressed in the adult lung, and in fetal liver, lung, kidney, brain and spleen.
Database Links

HGNC: 13935

OMIM: 606038

KEGG: hsa:58530

STRING: 9606.ENSP00000364985

UniGene: Hs.591792

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*